KIT Kitron ASA

MedAvail awards contract to Kitron’s US factory

MedAvail awards contract to Kitron’s US factory

(2020-08-25) MedAvail Technologies has chosen Kitron to produce automated medication dispensing equipment for pharmacies and hospitals.

The contract has a potential value of USD 50 million over a three-year period, with an extension option.

Production will take place at Kitron’s newly renovated facility in Windber, Pennsylvania, and is expected to commence in the first quarter of 2021.

“We have awarded this important contract to Kitron after a thorough process. Among the deciding factors were Kitron’s broad experience with customers in the medical devices industry and its familiarity with the particular requirements this entails. We’re extremely pleased to enter into this production partnership,” said Ed Kilroy, CEO of MedAvail Technologies.

MedAvail has developed a world leading consumer facing pharmacy automation kiosk, the MedAvail MedCenter. This technology is taken to market by MedAvail through their own retail pharmacy network, branded SpotRx Pharmacy. The MedCenter technology, combined with other features, enables SpotRx to deploy directly in-clinic providing on site dispensing and access to a live pharmacist via the MedAvail MedCenter. SpotRx is focused on the US Medicare market. MedAvail also licenses the MedCenter technology to a select group of large retailers and health systems. 

“This agreement is strategically important for Kitron. The upgrades and investments we have made at our US facility played a key role in securing this business, which significantly boosts our presence within the Medical devices market sector in North-America,” said Peter Nilsson, President and CEO of Kitron ASA.

For further information, please contact:

Kitron: Peter Nilsson, President and CEO, tel.  850

Israel Losada Salvador, COO and Sales Director, tel. +47 991 59 138

E-mail:

MedAvail Technologies:

Ed Kilroy, CEO, tel.

Ryan Ferguson, CFO, tel.

E-mail:  

Kitron is a leading Scandinavian electronics manufacturing services company for the Defence/Aerospace, Energy/Telecoms, Industry, Medical devices and Offshore/Marine sectors. The company is located in Norway, Sweden, Lithuania, Germany, Poland, China and the United States. Kitron had revenues of about NOK 3.3 billion in 2019 and has about 1 700 employees.  

This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

 

EN
25/08/2020

Underlying

KITKitron ASA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Kitron ASA

Free Trial
KIT KITRON ASA

Kitron ASA: 1 director

A director at Kitron ASA sold 100,000 shares at 105.770NOK and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

02/23/26 February 23, 2026 1 EN
 PRESS RELEASE
Free
KIT KITRON ASA

Kitron ASA - Notification of Primary insider transaction

Kitron ASA - Notification of Primary insider transaction (2026-02-23) Primary insider Zygimantas Dirse, VP Asia in Kitron ASA, has today sold 100,000 shares in Kitron ASA with an average price of approx. NOK 105.77 per share. The sale has been made pursuant to a previously announced exemption under the lock-up undertakings made in connection with Kitron ASA’s private placement in November 2025 allowing two individuals to sell an aggregated total of up to 200,000 shares. Following today’s sale Zygimantas Dirse will not be entitled to sell any additional shares under the referenced exemption....

February 23, 2026 1 EN
 PRESS RELEASE
Free
KIT KITRON ASA

Kitron: Allocation of options

Kitron: Allocation of options (2026-02-12) On 12 February 2026, the board of directors of Kitron ASA (the "Company" or "Kitron") resolved to issue 800 000 options under Kitron's long- term incentive program for the period 2024 - 2030. The options are issued with 800 000 options in Subprogram C (2026 - 2029), and in accordance with the board of directors' guidelines for remuneration of senior executives as approved by Kitron's annual general meeting held 25 April 2024. The share option program and properties of the options are a continuation of Kitron's share option program as described in...

February 12, 2026 1 EN
 PRESS RELEASE
Free
KIT KITRON ASA

Kitron: Allokering av opsjoner

Kitron: Allokering av opsjoner (2026-02-12) Styret i Kitron ASA ("Selskapet" eller "Kitron") vedtok 12. februar 2026 å utstede 800 000 opsjoner i henhold til Kitrons langsiktige insentivprogram for perioden 2024 - 2030. Opsjonene blir utstedt med 800 000 opsjoner i C (2026 - 2029), og i henhold til styrets retningslinjer for godtgjørelse til ledende ansatte som vedtatt av ordinær generalforsamlingavholdt 25. april 2024. Aksjeopsjonsprogrammet og egenskapene til opsjonene er en fortsettelse av Kitrons opsjonsprogram som beskrevet i note 19 til Selskapets årsregnskap for 2024. Totalt er det...

February 12, 2026 1 EN
ABGSC Capital Goods Research ... (+3)
  • ABGSC Capital Goods Research
  • Åsne Holsen
  • Øystein Elton Lodgaard
02/12/26 February 12, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch